ANNEXON INC
ANNX · NASDAQ
Updated at 2026-10-15 06:44:56
- Today's High
- $3.85
- Today’s Low
- $3.66
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $3.79
- Previous Close
- $3.67
- Volume
- 4.04M
- Market Cap
- $695.75M
- P/E Ratio
- --
- EPS
- $-1.14
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 1400 SIERRA POINT PARKWAY, BRISBANE, CA, UNITED STATES, 94005
- Country
- US
- Listing Date
- 2020-07-24
- Fiscal Year End
- December
- Shares Outstanding
- 163.84M
- CIK
- 0001528115
- Website
- annexonbio.com
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for autoimmune and neurodegenerative diseases. The company is headquartered in South San Francisco, California.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$57.22M
2026-03-31
$45.09M
2025-12-31
$49.31M
2025-09-30
$57.01M
Net Income
2026-06-30
-$55.34M
2026-03-31
-$44.14M
2025-12-31
-$48.25M
2025-09-30
-$54.92M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.28
2026-03-31
$-0.23
2025-12-31
$-0.28
2025-09-30
$-0.37
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$54.8M
2026-03-31
-$43.6M
2025-12-31
-$47.71M
2025-09-30
-$54.37M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $57.22M | $45.09M | $49.31M | $57.01M |
| Net Income | -$55.34M | -$44.14M | -$48.25M | -$54.92M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.28 | $-0.23 | $-0.28 | $-0.37 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$54.8M | -$43.6M | -$47.71M | -$54.37M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.